674 related articles for article (PubMed ID: 25778500)
1. Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus: A Systematic Review of Clinical Practice Guidelines.
Tunnicliffe DJ; Singh-Grewal D; Kim S; Craig JC; Tong A
Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1440-52. PubMed ID: 25778500
[TBL] [Abstract][Full Text] [Related]
2. [Neuropsychiatric lupus and lupus nephritis as a clinical manifestations of systemic lupus erythematosus].
Rasić S; Dzemidzić J; Srna A; Aganović K; Rebić D; Muslimović A
Med Arh; 2005; 59(6):393-5. PubMed ID: 16268075
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
Wang M; Gladman DD; Ibañez D; Urowitz MB
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
[TBL] [Abstract][Full Text] [Related]
4. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.
Bertsias G; Ioannidis JP; Boletis J; Bombardieri S; Cervera R; Dostal C; Font J; Gilboe IM; Houssiau F; Huizinga T; Isenberg D; Kallenberg CG; Khamashta M; Piette JC; Schneider M; Smolen J; Sturfelt G; Tincani A; van Vollenhoven R; Gordon C; Boumpas DT;
Ann Rheum Dis; 2008 Feb; 67(2):195-205. PubMed ID: 17504841
[TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus: a case-based presentation of renal, neurologic, and hematologic emergencies.
Campbell EJ; Clarke AE; Ramsey-Goldman R
Expert Rev Clin Immunol; 2018 Oct; 14(10):803-816. PubMed ID: 30173578
[TBL] [Abstract][Full Text] [Related]
6. Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients.
Chavatza K; Kostopoulou M; Nikolopoulos D; Gioti O; Togia K; Andreoli L; Aringer M; Boletis J; Doria A; Houssiau FA; Jayne D; Mosca M; Svenungsson E; Tincani A; Bertsias G; Fanouriakis A; Boumpas DT
Ann Rheum Dis; 2021 Sep; 80(9):1175-1182. PubMed ID: 34162597
[TBL] [Abstract][Full Text] [Related]
7. [Neuropsychiatric systemic lupus erythematosus (1st part). Cases definitions and diagnosis and treatment of central nervous system and psychiatric manifestations of systemic lupus erythematosus].
Lefèvre G; Zéphir H; Warembourg F; Michelin E; Pruvo JP; Hachulla E; Semah F; Dubucquoi S; Lenfant P; Vermersch P; Hatron PY; Prin L; Launay D
Rev Med Interne; 2012 Sep; 33(9):491-502. PubMed ID: 22579860
[TBL] [Abstract][Full Text] [Related]
8. Neuro-ophthalmologic manifestations of systemic lupus erythematosus: a systematic review.
Man BL; Mok CC; Fu YP
Int J Rheum Dis; 2014 Jun; 17(5):494-501. PubMed ID: 24673755
[TBL] [Abstract][Full Text] [Related]
9. Racial and Ethnic Differences in the Prevalence and Time to Onset of Manifestations of Systemic Lupus Erythematosus: The California Lupus Surveillance Project.
Maningding E; Dall'Era M; Trupin L; Murphy LB; Yazdany J
Arthritis Care Res (Hoboken); 2020 May; 72(5):622-629. PubMed ID: 31115180
[TBL] [Abstract][Full Text] [Related]
10. Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in Canada.
Keeling SO; Bissonauth A; Bernatsky S; Vandermeer B; Fortin PR; Gladman DD; Peschken C; Urowitz MB
J Rheumatol; 2018 Oct; 45(10):1440-1447. PubMed ID: 30068762
[TBL] [Abstract][Full Text] [Related]
11. Clinical practice guidelines and recommendations for the management of patients with systemic lupus erythematosus: a critical comparison.
Oliveira M; Palacios-Fernandez S; Cervera R; Espinosa G
Rheumatology (Oxford); 2020 Dec; 59(12):3690-3699. PubMed ID: 32375178
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychiatric manifestations are not uncommon in Indian lupus patients and negatively affect quality of life.
Muhammed H; Goyal M; Lal V; Singh S; Dhir V
Lupus; 2018 Apr; 27(4):688-693. PubMed ID: 29241417
[TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients.
Houman MH; Smiti-Khanfir M; Ben Ghorbell I; Miled M
Lupus; 2004; 13(3):204-11. PubMed ID: 15119551
[TBL] [Abstract][Full Text] [Related]
14. Vasculitis and vasculopathy in Lupus Nephritis: Clinical variability, outcome, and new insight into treatment.
Kaul A; Agrawal V; Bhaduaria D; Agrawal V; Prasad N; Gupta A; Sharma RK
Saudi J Kidney Dis Transpl; 2017; 28(2):415-424. PubMed ID: 28352031
[TBL] [Abstract][Full Text] [Related]
15. [Neuropsychiatric systemic lupus erythematosus (2nd part). Diagnostic and treatment tools in psychiatric or central nervous system manifestations in systemic lupus erythematosus].
Lefèvre G; Zéphir H; Michelin E; Semah F; Warembourg F; Pruvo JP; Hachulla E; Lenfant P; Dubucquoi S; Vermersch P; Hatron PY; Prin L; Launay D
Rev Med Interne; 2012 Sep; 33(9):503-13. PubMed ID: 22578589
[TBL] [Abstract][Full Text] [Related]
16. [New perspectives in the classification and treatment of systemic lupus erythematosus: the central role of kidney involvement].
Cavagna L; Scorletti E; Romano M; Cagnotto G; Caporali R
G Ital Nefrol; 2013; 30(4):. PubMed ID: 24403199
[TBL] [Abstract][Full Text] [Related]
17. Current role of rituximab in systemic lupus erythematosus.
Mok CC
Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus.
Lazzaroni MG; Dall'Ara F; Fredi M; Nalli C; Reggia R; Lojacono A; Ramazzotto F; Zatti S; Andreoli L; Tincani A
J Autoimmun; 2016 Nov; 74():106-117. PubMed ID: 27377453
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus.
Iwata S; Saito K; Hirata S; Ohkubo N; Nakayamada S; Nakano K; Hanami K; Kubo S; Miyagawa I; Yoshikawa M; Miyazaki Y; Yoshinari H; Tanaka Y
Lupus; 2018 Apr; 27(5):802-811. PubMed ID: 29308726
[TBL] [Abstract][Full Text] [Related]
20. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
